MedTrace Logo

NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE)

NCT07370571 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 827

Last updated 2026-01-27

No results posted yet for this study

Summary

Prospective study will establish a comprehensive international registry specifically for patients who have undergone surgery for primary breast cancer without SLNB. The main objective of this registry is to gather detailed, real-world data on the outcomes of this particular treatment approach, providing insights into the clinical efficacy and quality of life of patients when SLNB is omitted.

Conditions

Interventions

PROCEDURE

Omission SLN

Omission SLN

Sponsors & Collaborators

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2027-03-30
Completion
2032-03-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07370571 on ClinicalTrials.gov